Ma, Ronald C. W.
Funding for this research was provided by:
Health and Medical Research Fund (13140761)
Research Grants Council, University Grants Committee (Theme-based Research Scheme (T12-402/13N))
The Chinese University of Hong Kong (Vice-Chancellor One-off Discretionary Fund)
Article History
Received: 6 September 2017
Accepted: 21 November 2017
First Online: 1 February 2018
Change Date: 18 April 2018
Change Type: Correction
Change Details: Unfortunately, the reference given in the legend to Fig. 2 was incorrect. The legend should have stated that Fig. 2 was drawn based on data from reference [49].
Duality of interest
: RCWM received research funding from AstraZeneca, Bayer, Boehringer Ingelheim, Merck Sharp & Dohme, Pfizer and Takeda for conducting clinical trials, speaker honorarium or consultancy in advisory boards. All proceeds have been donated to the Chinese University of Hong Kong to support diabetes research.